Latest Neurochemistry Stories

SUNNYVALE, Calif., Jan. 28, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis centered around its patented therapeutic protein MANF, today announced the launch of the Company's new website at www.amarantus.com. "2012 was an exceptionally productive year for Amarantus with the acquisition of two diagnostic platforms to expand...

redOrbit Staff & Wire Reports - Your Universe Online A panel of medical experts is advising the US Food and Drug Administration (FDA) to tighten restrictions on painkillers that contain the substance hydrocodone – a move intended to make it more difficult to prescribe and, ideally, help to curb abuse of the addictive substance. According to Reuters, the panel voted 19-10 in favor of reclassifying all medications containing less than 15 milligrams of hydrocodone, which include...

Alan McStravick for redOrbit.com - Your Universe Online Addiction is a serious disorder of the brain that is characterized by a chronic and compulsive need to take a substance, typically with an increase in dosage and frequency. Someone suffering from addiction will continue their behavior even in the face of negative consequences. The root cause of addiction is not specifically known, however. A new study out of the University of Texas at Austin (UT) may just point to one indicator of...

With a new insight into a model of Parkinson’s disease, researchers from the University of Pennsylvania School of Veterinary Medicine have identified a novel target for mitigating some of the disease’s toll on the brain. Narayan G. Avadhani, Harriet Ellison Woodward Professor of Biochemistry and chair of the Department of Animal Biology at Penn Vet, was the senior author on the research. Other department members contributing to the work included Prachi Bajpai, Michelle C. Sangar,...

CANTON, Mass., Jan. 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to Canton, Massachusetts from Cumberland, Rhode Island. The Company's lead development program is Oxycodone DETERx(®) (COL-003), a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx(®...

MINNEAPOLIS, Jan. 16, 2013 /PRNewswire/ -- Today, the ClearWay Minnesota Board of Directors approved two new research grants that will fund studies examining menthol cigarettes in Minnesota. A third grant, also for a menthol-focused research project, was approved by the Board in November. Research grantees the University of Minnesota and the Public Health Law Center will receive more than $360,000 through these awards. "We know menthol cigarettes increase smoking initiation...

POINT RICHMOND, Calif., Jan. 10, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) - The FDA is requiring that the manufacturers of certain zolpidem based prescription sleep aids such as Ambien® and Ambien CR®, and generic versions of these products, reduce the recommended dose. FDA has informed the manufacturers of these products that the recommended dose of zolpidem at bedtime for women should be lowered from 10 mg to 5 mg for immediate-release products such...

SUNNYVALE, Calif., Jan. 10, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF), today announced that a corporate presentation made by President & CEO Gerald E. Commissiong on Wednesday January 9, 2013 at Biotech Showcase 2013...

April Flowers for redOrbit.com - Your Universe Online A research team from Inserm has published a new study in the journal Biological Psychology detailing the key role played by a protein, the CB1 cannabinoid receptor, during physical exercise. The team demonstrated, in studies conducted on mice, the location of this receptor - in a part of the brain associated with motivation and reward systems - controls the amount of time for which an individual will carry out voluntary physical...

SAINT PAUL, Minn., Jan. 3, 2013 /PRNewswire/ -- ClearWay Minnesota(SM) , in partnership with ECHO (Emergency, Community, Health, and Outreach), has created a multilingual television program, The Harm of Commercial Tobacco in Our Community, to educate Minnesota's diverse populations about the dangers of tobacco. The program discusses the seriousness of tobacco use, the targeting of immigrants and ethnic groups by tobacco companies, and the benefits of quitting. "Even though...